Movatterモバイル変換


[0]ホーム

URL:


CN105218428A - A kind of preparation method of Apremilast of high chiral purity - Google Patents

A kind of preparation method of Apremilast of high chiral purity
Download PDF

Info

Publication number
CN105218428A
CN105218428ACN201510677834.0ACN201510677834ACN105218428ACN 105218428 ACN105218428 ACN 105218428ACN 201510677834 ACN201510677834 ACN 201510677834ACN 105218428 ACN105218428 ACN 105218428A
Authority
CN
China
Prior art keywords
methoxyphenyl
compound
ethoxy
methylsulfonyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510677834.0A
Other languages
Chinese (zh)
Inventor
黄乐群
胡丰锦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Meijia Ningyi Medicine Research Development Co Ltd
Original Assignee
Nanjing Meijia Ningyi Medicine Research Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Meijia Ningyi Medicine Research Development Co LtdfiledCriticalNanjing Meijia Ningyi Medicine Research Development Co Ltd
Priority to CN201510677834.0ApriorityCriticalpatent/CN105218428A/en
Publication of CN105218428ApublicationCriticalpatent/CN105218428A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention discloses a kind of preparation method of Apremilast of high chiral purity, 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and N-ethanoyl-L-Leu salt-forming reaction obtain (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-? does N-ethanoyl-L-Leu salt react generation with 3-kharophen Tetra hydro Phthalic anhydride again and obtains under toluene and acetic acid existent condition? (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-diketone, the purer Apremilast of steric isomer is obtained by acetone and alcohol mixed solvent recrystallization.The invention has the advantages that: the present invention, by changing solvent, adding catalyzer, substantially reduces the reaction times, and obtained chiral purity is up to the Apremilast of 99.8%.

Description

A kind of preparation method of Apremilast of high chiral purity
Technical field
The invention belongs to field of medicine and chemical technology, be specifically related to a kind of Apremilast of high chiral purity
Preparation method.
Background technology
Apremilast chemistry (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-diketone by name, its chemical structural formula is:
Apremilast obtains U.S. FDA approval listing on March 25th, 2014, and commodity are called Otezla, are used for the treatment of psoriatic arthritis.Apremilast is phosphodiesterase (PDE4) the inhibitor class new small molecule oral medicine of first granted listing, manufactured by the Celgene company of New Jersey Summit, there is good curative effect and high security, change the current treatment status of global psoriatic arthritis.
Existing but (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1; 3-diketone is by 3-acetamido Tetra hydro Phthalic anhydride and (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine flows reaction overnight next time in the situation that acetic acid is solvent and generates; long reaction time, and the chiral purity of Apremilast reduces.
Summary of the invention
The object of the invention is to for the deficiencies in the prior art, a kind of high chiral purity is now provided
The preparation method of Apremilast.
For achieving the above object, technical scheme of the present invention is: a kind of preparation method of Apremilast of high chiral purity, its innovative point is: described preparation method is as follows: by compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and compound N-acetyl-L-Leu salt-forming reaction obtain compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, compound (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt reacts generation again and obtains compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1 under toluene and acetic acid existent condition with compound 3-kharophen Tetra hydro Phthalic anhydride, 3-diketone, the purer Apremilast of steric isomer is obtained by the mixed solvent recrystallization of acetone and ethanol.
Further, described compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete preparation method of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction, select the methyl alcohol of 280 ~ 420ml as under the condition of solvent, by 40 ~ 60g compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and 16 ~ 22g compound N-acetyl-L-Leu salt-forming reaction obtain 40 ~ 60g compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt.
Further; described compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete purification process of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select 220 ~ 420ml methyl alcohol as solvent; refining (the S)-2-(3-ethoxy-4-methoxyphenyl obtaining purifying under reflux temperature)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, described reflux temperature is 65 ~ 70 DEG C.
Further, described compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, the concrete preparation method of 3-diketone is: select 320 ~ 480ml toluene to be solvent, 32 ~ 48ml acetic acid is catalyzer, 16 ~ 24g compound (S)-2-(3-ethoxy-4-methoxyphenyl by after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt and 8 ~ 12g compound 3-kharophen Tetra hydro Phthalic anhydride react 2 ~ 3h at a reflux temperature, obtain 16 ~ 24g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-diketone, described reflux temperature is 110 ~ 120 DEG C.
Further; the preparation method of the Apremilast of described high chiral purity is specially: by 16 ~ 24g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1; 3-diketone puts into solvent; under 50 ~ 60 DEG C of conditions, recrystallization obtains high purity Apremilast, and described solvent is the mixture of 64 ~ 96ml acetone and 126 ~ 192ml ethanol.
Beneficial effect of the present invention is as follows: the present invention is by changing solvent, adding catalyzer, substantially reduce the reaction times, obtained Apremilast crude product, again through acetone and alcohol mixed solvent recrystallization, effectively can suppress the upset of chiral centre in Apremilast building-up process, thus obtained chiral purity is up to the Apremilast of 99.6%.
Embodiment
By particular specific embodiment, embodiments of the present invention are described below, person skilled in the art scholar the content disclosed by this specification sheets can understand other advantages of the present invention and effect easily.
Reactional equation of the present invention is as follows:
Embodiment 1
A kind of preparation method of Apremilast of high chiral purity, by compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and compound N-acetyl-L-Leu salt-forming reaction obtain compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, compound (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt reacts generation again and obtains compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1 under toluene and acetic acid existent condition with compound 3-kharophen Tetra hydro Phthalic anhydride, 3-diketone, the purer Apremilast of steric isomer is obtained by the mixed solvent recrystallization of acetone and ethanol.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete preparation method of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select the methyl alcohol of 280ml as under the condition of solvent, by 40g compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and 16g compound N-acetyl-L-Leu salt-forming reaction obtain 40g compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete purification process of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select 220ml methyl alcohol as solvent; refining (the S)-2-(3-ethoxy-4-methoxyphenyl obtaining purifying under reflux temperature)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, reflux temperature is 65 DEG C.
Compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, the concrete preparation method of 3-diketone is: select 320ml toluene to be solvent, 32ml acetic acid is catalyzer, 16g compound (S)-2-(3-ethoxy-4-methoxyphenyl by after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt and 8g compound 3-kharophen Tetra hydro Phthalic anhydride react 2 ~ 3h at a reflux temperature, obtain 16g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-diketone, reflux temperature is 110 DEG C.
The preparation method of the Apremilast of high chiral purity is specially: by 16g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1; 3-diketone puts into solvent; under 50 ~ 60 DEG C of conditions, recrystallization obtains high purity Apremilast, and solvent is the mixture of 64ml acetone and 126ml ethanol.
The chiral purity of the Apremilast that the present embodiment obtains is up to 99.6%.
Embodiment 2
A kind of preparation method of Apremilast of high chiral purity, by compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and compound N-acetyl-L-Leu salt-forming reaction obtain compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, compound (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt reacts generation again and obtains compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1 under toluene and acetic acid existent condition with compound 3-kharophen Tetra hydro Phthalic anhydride, 3-diketone, the purer Apremilast of steric isomer is obtained by the mixed solvent recrystallization of acetone and ethanol.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete preparation method of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select the methyl alcohol of 420ml as under the condition of solvent, by 60g compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and 22g compound N-acetyl-L-Leu salt-forming reaction obtain 60g compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete purification process of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select 420ml methyl alcohol as solvent; refining (the S)-2-(3-ethoxy-4-methoxyphenyl obtaining purifying under reflux temperature)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, reflux temperature is 70 DEG C.
Compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, the concrete preparation method of 3-diketone is: select 480ml toluene to be solvent, 48ml acetic acid is catalyzer, 24g compound (S)-2-(3-ethoxy-4-methoxyphenyl by after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt and 12g compound 3-kharophen Tetra hydro Phthalic anhydride react 2 ~ 3h at a reflux temperature, obtain 24g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-diketone, reflux temperature is 120 DEG C.
The preparation method of the Apremilast of high chiral purity is specially: by 24g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1; 3-diketone puts into solvent; under 50 ~ 60 DEG C of conditions, recrystallization obtains high purity Apremilast, and solvent is the mixture of 96ml acetone and 192ml ethanol.
The chiral purity of the Apremilast that the present embodiment obtains is up to 99.6%.
Embodiment 3
A kind of preparation method of Apremilast of high chiral purity, by compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and compound N-acetyl-L-Leu salt-forming reaction obtain compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, compound (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt reacts generation again and obtains compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1 under toluene and acetic acid existent condition with compound 3-kharophen Tetra hydro Phthalic anhydride, 3-diketone, the purer Apremilast of steric isomer is obtained by the mixed solvent recrystallization of acetone and ethanol.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete preparation method of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select the methyl alcohol of 350ml as under the condition of solvent, by 50g compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and 19g compound N-acetyl-L-Leu salt-forming reaction obtain 50g compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt.
Compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl) the concrete purification process of-ethyl-2-base amine-N-ethanoyl-L-Leu salt is: be 65 ~ 70 DEG C in temperature of reaction; select 320ml methyl alcohol as solvent; refining (the S)-2-(3-ethoxy-4-methoxyphenyl obtaining purifying under reflux temperature)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, reflux temperature is 67 DEG C.
Compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, the concrete preparation method of 3-diketone is: select 400ml toluene to be solvent, 40ml acetic acid is catalyzer, 20g compound (S)-2-(3-ethoxy-4-methoxyphenyl by after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt and 10g compound 3-kharophen Tetra hydro Phthalic anhydride react 2 ~ 3h at a reflux temperature, obtain 20g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-diketone, reflux temperature is 115 DEG C.
The preparation method of the Apremilast of high chiral purity is specially: by 20g compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1; 3-diketone puts into solvent; under 50 ~ 60 DEG C of conditions, recrystallization obtains high purity Apremilast, and solvent is the mixture of 80ml acetone and 159ml ethanol.
The chiral purity of the Apremilast that the present embodiment obtains is up to 99.8%.
The present invention is by changing solvent, adding catalyzer, substantially reduce the reaction times, obtained Apremilast crude product, through acetone and alcohol mixed solvent recrystallization, effectively can suppress the upset of chiral centre in Apremilast building-up process, thus obtained chiral purity is up to the Apremilast of 99.8%.
Above-described embodiment is preferred embodiment of the present invention; it is not the restriction to technical solution of the present invention; as long as without the technical scheme that creative work can realize on the basis of above-described embodiment, all should be considered as falling within the scope of the rights protection of patent of the present invention.

Claims (5)

1. the preparation method of the Apremilast of a high chiral purity, it is characterized in that: described preparation method is as follows: by compound 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine and compound N-acetyl-L-Leu salt-forming reaction obtain compound (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt, compound (S)-2-(3-ethoxy-4-methoxyphenyl after purifying)-1-(methylsulfonyl)-ethyl-2-base amine-N-ethanoyl-L-Leu salt reacts generation again and obtains compound (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1 under toluene and acetic acid existent condition with compound 3-kharophen Tetra hydro Phthalic anhydride, 3-diketone, the purer Apremilast of steric isomer is obtained by the mixed solvent recrystallization of acetone and ethanol.
CN201510677834.0A2015-10-202015-10-20A kind of preparation method of Apremilast of high chiral purityPendingCN105218428A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201510677834.0ACN105218428A (en)2015-10-202015-10-20A kind of preparation method of Apremilast of high chiral purity

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201510677834.0ACN105218428A (en)2015-10-202015-10-20A kind of preparation method of Apremilast of high chiral purity

Publications (1)

Publication NumberPublication Date
CN105218428Atrue CN105218428A (en)2016-01-06

Family

ID=54987769

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201510677834.0APendingCN105218428A (en)2015-10-202015-10-20A kind of preparation method of Apremilast of high chiral purity

Country Status (1)

CountryLink
CN (1)CN105218428A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106187857A (en)*2016-06-302016-12-07浙江华海药业股份有限公司A kind of method preparing Apremilast
CN106995401A (en)*2016-01-292017-08-01浙江京新药业股份有限公司A kind of method for preparing high-optical-purity Apremilast
CN107628983A (en)*2017-05-192018-01-26杭州华东医药集团新药研究院有限公司The Apremilast of high chiral purity

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101683334A (en)*2002-03-202010-03-31细胞基因公司(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
WO2010147922A1 (en)*2009-06-182010-12-23Concert Pharmaceuticals, Inc.Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
CN102046167A (en)*2008-03-272011-05-04细胞基因公司 Contains (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3- Solid forms of diketones, compositions thereof and uses thereof
CN102558022A (en)*2010-12-222012-07-11康塞特医药品有限公司 Substituted isoindoline-1,3-dione derivatives
CN102781443A (en)*2009-11-192012-11-14细胞基因公司Apremilast For The Treatment Of Sarcoidosis
US20130217919A1 (en)*2012-02-212013-08-22Celgene CorporationAsymmetric synthetic processes for the preparation of aminosulfone compounds
CN103442698A (en)*2010-12-162013-12-11细胞基因公司Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CN104478790A (en)*2014-12-162015-04-01南京艾德凯腾生物医药有限责任公司Preparation method of S-type apremilast
CN104529869A (en)*2014-12-192015-04-22苏州亚宝药物研发有限公司Preparation method of (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonyl ethyl]-4-acetyl amino isoindoline-1, 3-diketone isomer

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101683334A (en)*2002-03-202010-03-31细胞基因公司(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
CN102046167A (en)*2008-03-272011-05-04细胞基因公司 Contains (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3- Solid forms of diketones, compositions thereof and uses thereof
WO2010147922A1 (en)*2009-06-182010-12-23Concert Pharmaceuticals, Inc.Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
CN102781443A (en)*2009-11-192012-11-14细胞基因公司Apremilast For The Treatment Of Sarcoidosis
CN103442698A (en)*2010-12-162013-12-11细胞基因公司Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CN102558022A (en)*2010-12-222012-07-11康塞特医药品有限公司 Substituted isoindoline-1,3-dione derivatives
US20130217919A1 (en)*2012-02-212013-08-22Celgene CorporationAsymmetric synthetic processes for the preparation of aminosulfone compounds
CN104478790A (en)*2014-12-162015-04-01南京艾德凯腾生物医药有限责任公司Preparation method of S-type apremilast
CN104529869A (en)*2014-12-192015-04-22苏州亚宝药物研发有限公司Preparation method of (S)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonyl ethyl]-4-acetyl amino isoindoline-1, 3-diketone isomer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALEXANDER L. RUCHELMAN,等: "Enantioselective synthesis of the apremilast aminosulfone using catalytic asymmetric hydrogenation", 《TETRAHEDRON: ASYMMETRY》*
HON-WAH MAN,等: "Discovery of (S)-N-{2-[1-(3-Ethoxy-4-methoxy phenyl)-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast),a Potent and Orally Active Phosphodiesterase 4 and Tumor Necrosis Factor-a Inhibitor", 《JOURNAL OF MEDICINAL CHEMISTRY》*
江珊,等: "阿普司特的合成工艺研究", 《广州化工》*
赵倩,等: "磷酸二酯酶-4抑制剂阿普司特", 《现代药物与临床》*

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106995401A (en)*2016-01-292017-08-01浙江京新药业股份有限公司A kind of method for preparing high-optical-purity Apremilast
CN106995401B (en)*2016-01-292019-07-26浙江京新药业股份有限公司A method of preparing high-optical-purity Apremilast
CN106187857A (en)*2016-06-302016-12-07浙江华海药业股份有限公司A kind of method preparing Apremilast
WO2018001353A1 (en)*2016-06-302018-01-04浙江华海药业股份有限公司Method for preparing apremilast
US10781173B2 (en)2016-06-302020-09-22Zhejiang Huahai Pharmaceutical Co., LtdMethod for preparing apremilast
CN107628983A (en)*2017-05-192018-01-26杭州华东医药集团新药研究院有限公司The Apremilast of high chiral purity

Similar Documents

PublicationPublication DateTitle
Yu et al.An efficient t-BuOK promoted C3-chalcogenylation of indoles with dichalcogenides
CN115666563A (en) Compositions and methods of substituted 7-(piperazin-1-yl)pyrazolo[1,5-A]pyrimidine analogs as KRAS inhibitors
CN104761474B (en)A kind of synthetic method of Apremilast chiral amine intermediates
BR112013026186A2 (en) continuously operable process for the preparation of carbonyl compounds by means of a catalyst containing a nitroxyl radical
KR20170032473A (en)Diazepane derivatives and uses thereof
CN105218428A (en)A kind of preparation method of Apremilast of high chiral purity
Kanhed et al.Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis
CN103641722A (en)Production method for 2-nitrobenzyl bromide
CN108276409B (en)Method for preparing medicine and medicine intermediate by continuous solid-liquid-gas three-phase reaction
Zhu et al.A novel and efficient asymmetric synthesis of anti-HIV drug maraviroc
CN103772402A (en)Novel refining method of asenapine maleate crude product
CN104326954A (en)Synthesis method of fudosteine
CN104761602B (en)A kind of preparation method of Trifluridine
Wang et al.Safe and highly efficient syntheses of triazole drugs using Cu2O nanoparticle in aqueous solutions
He et al.Highly efficient synthesis of 9-aminoxanthenes via the tandem reaction of arynes with salicyl N-tosylimines
Kułaga et al.Microwave‐assisted solvent‐free synthesis of ipsapirone
Bernstein et al.Phenothiazine Chemistry. I. 10-Sulfanilylphenothiazine and Other 10-Substituted Phenothiazine Derivatives1
Zhu et al.A novel and practical asymmetric synthesis of dapoxetine hydrochloride
CN106866425B (en) A kind of green synthesis method of bromo aromatic amine and α-bromo aromatic ketone
CN106008499B (en)A kind of method for preparing CDK46 kinase inhibitors Pa Boxini
CN108069839A (en)Alkene is converted into the method for alpha- bromo ketone using C5H6Br2N2O2
WO2022225866A1 (en)Quinazoline derivatives, pharmaceutical compositions, and therapeutic uses related to nox inhibition
CN103288757B (en)Preparation method of 6-amino-7-hydroxyl-3,4-dihydroquinazoline-4-ketone
CN101580473A (en)Method for preparing N-methyl paranitroaniline
CN103254134B (en)Synthesis method of polysubstituted imidazole

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20160106

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp